The S-3/A is a required step to register PIPE shares for the Eos merger, signaling deal progress. However, the conversion price is far above market, so near-term selling pressure is limited. Monitor the stockholder vote on the merger and Nasdaq listing approval, these are the key catalysts. The stock will likely trade on merger probability rather than fundamentals.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 10 $1.57entry
- T+1 · 3mo ago +1.91%α +2.23% · $1.60
- T+5 · 3mo ago −0.64%α −0.59% · $1.56
- T+20 · 2mo ago −11.15%α −10.23% · $1.40
- T+60 · 14d ago −15.29%α −12.87% · $1.33
Price Chart
How similar events traded
Executive Summary
Pulmatrix filed Amendment No. 1 to its S-3 shelf registration to register the resale of up to 490,910 shares of common stock (including 36,364 dividend shares) issuable upon conversion of Series B Convertible Preferred Stock held by RCM Eos PIPE HOLDINGS, LLC. The preferred shares were issued in a $1.0M private placement tied to the pending reverse merger with Eos SENOLYTIX, under which current Pulmatrix stockholders will own only ~6% of the combined company. The filing is a procedural step toward closing the merger, but the company receives no proceeds and the registration enables future selling by the investor, adding overhang to an already distressed micro-cap.
Key Financial Metrics
Key Facts
- Registers 490,910 shares for resale: 454,546 conversion shares at $2.20 per share plus 36,364 dividend shares (8% annual dividend on $1,000 stated value).
- Shares represent ~13% of current 3,652,285 shares outstanding as of May 27, 2026.
- Company receives no proceeds from the resale; selling stockholder is RCM Eos PIPE HOLDINGS, LLC (affiliate of merger counterparty Eos).
- Conversion price of $2.20 is well above the last reported price of $1.29 (June 3, 2026), so conversion is unlikely unless the stock price rises or the merger closes (automatic conversion).
- Q1 2026 financials: cash $3.3M, net loss $1.17M, accumulated deficit $303.5M; minimal R&D spend ($3K) indicates a virtual shell company.
- Pending merger with Eos would result in current Pulmatrix stockholders owning ~6% of the combined company on a fully-diluted basis.
Financial Impact
Potential dilution of ~13% from conversion shares if converted; merger would cause ~94% ownership dilution for current shareholders. No immediate cash impact to company.
Risk Factors
- Merger may fail to close (stockholder approval, Nasdaq listing, or other conditions).
- If merger closes, automatic conversion and eventual resale by the investor could pressure the stock.
- Company has minimal cash runway (~3 quarters at current burn) with no revenue; failure of merger could lead to dissolution.
- Current market price ($1.29) well below conversion price ($2.20) limits immediate dilution but reflects weak demand.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001493152-26-036642 |
| Exhibit: ex23-1.htm | 0001493152-26-036642 |
| Exhibit: ex23-2.htm | 0001493152-26-036642 |
| Exhibit: ex23-3.htm | 0001493152-26-036642 |
| Document: 0001493152-26-036642-index-headers.html | 0001493152-26-036642 |
| Document: 0001493152-26-036642-index.html | 0001493152-26-036642 |
| Document: 0001493152-26-036642.txt | 0001493152-26-036642 |
Track record
21 reports on PULM
5 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +8.61% at T+60 after the Aug 13, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 9, 20267d ago 425 Neutral 3/10 Entry $1.36 to $1.33 Now $1.33 −1.85% ▼ −1.84% −0.15% vs SPY
- Oct 30, 202617d ago 425 Neutral 3/10 Entry $1.40 to $1.38 Now $1.33 −5.00% ▼ −1.43% +1.27% vs SPY
- Oct 23, 202625d ago EFFECT Bearish 5/10 Entry $1.48 to $1.40 Now $1.33 +10.14% ▲ +5.41% +4.85% vs SPY
- Oct 22, 202625d ago 425 Neutral 4/10 Entry $1.42 to $1.41 Now $1.33 −6.34% ▼ −0.70% −1.41% vs SPY
- Oct 13, 20264w ago 425 Neutral 4/10 Entry $1.38 to $1.43 Now $1.33 −3.62% ▲ +3.62% +4.77% vs SPY
- Oct 7, 20265w ago DEFA14A Neutral 2/10 Entry $1.53 to $1.41 Now $1.33 −12.91% ▼ −7.67% −7.39% vs SPY
- Oct 2, 20266w ago S-3/A Bearish 5/10 Entry $1.48 to $1.43 Now $1.33 +10.14% ▲ +3.38% +3.80% vs SPY
- Sep 28, 20267w ago EFFECT Bearish 5/10 Entry $1.59 to $1.48 Now $1.33 +16.35% ▲ +6.92% +8.12% vs SPY
- Sep 25, 20267w ago DEFM14A Bearish 6/10 Entry $1.59 to $1.48 Now $1.33 +16.35% ▲ +6.92% +8.12% vs SPY
- Sep 23, 20267w ago S-4/A Neutral 2/10 Entry $1.67 to $1.54 Now $1.33 −20.36% ▼ −7.78% −7.37% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers